Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: laboratory criteria for the diagnosis and control of treatment efficacy
Journal Title: Міжнародний ендокринологічний журнал - Year 2019, Vol 15, Issue 5
Abstract
Non-classic congenital adrenal hyperplasia (NCAH) due to 21-hydroxylase deficiency is one of the actual causes of hyperandrogenic manifestations at different age intervals. Timely diagnosis of the disease requires evaluating basal 17-hydroxyprogesterone levels during the comprehensive examination of patients of different age groups with clinical manifestations of androgen excess. This is especially important when examining adolescent girls and women of reproductive age with signs of hyperandrogenism. The obligatory examination of women when establishing the diagnosis of polycystic ovary syndrome should include the exclusion of non-classical NCAH according to all world recommendations. When 17-hydroxyprogesterone levels are in the range of 2–10 ng/ml, it is necessary to carry out cosyntropin stimulation test, which is recognized worldwide as the standard of NCAH diagnosis. The diagnostic threshold for NCAH diagnosis due to 21-hydroxylase deficiency is a level of 17-hydroxyprogesterone, basal or stimulated in cosyntropin test, higher than 10 ng/ml. Genetic testing — determining mutations in the CYP21A2 gene — is an important and necessary tool not only to confirm the diagnosis, but also to identify treatment of the patient with the diagnosis of NCAH and to determine the risk of emergence of a classic form in an unborn child in the presence of allele associated with classic САН. The recent recommendations from 2018 Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline are taken as the basis of the laboratory diagnostic criteria.
Authors and Affiliations
O. V. Rykova
Keywords
Related Articles
- EP ID EP660859
- DOI 10.22141/2224-0721.15.5.2019.180044
- Views 62
- Downloads 0
Features of Hormone Therapy after Surgeries for Thyroid Cancer
No abstract
Synevo Day 2019: “Laboratory diagnosis — tomorrow that has come” (review of the conference)
.
New guidelines of the American Diabetes Association 2018 on the diagnosis and treatment of diabetes mellitus
The article considers some aspects of the recently published recommendations of the American Diabetes Association on the diagnosis, prevention and treatment of diabetes mellitus.
Atypical Forms of Autoimmune Thyroid Disease Course as a Manifestation of Autoimmune Overlap Syndrome
Autoimmune thyroid disorders are relatively frequent pathology. The pathogenesis of all autoimmune diseases is based on disorders of the immune tolerance in genetically predisposed individuals, which lead to the developm...
Epidemiology and socio-economic features of myocardial infarction and stroke in patients with type 2 diabetes mellitus
Background. The purpose was to study epidemiology and socio-economic features of myocardial infarction (МI) and stroke in patients with the type 2 diabetes mellitus (DM). Materials and methods. Patients were divided into...